Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,065-2,076 of 4,306
Drug study icon
CompletedNCT01895452

An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Bulgaria, Malaysia, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01175135

Efficacy, Safety, And Tolerability Of PF-02545920 for schizophrenia

This study is completed in the United States, in Germany, and in Ukraine. It is testing Efficacy, Safety, And Tolerability Of PF-02545920 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Germany, Ukraine
Sponsor
Pfizer
Condition
Schizophrenia
Other study type icon
CompletedNCT01634542

An Non-Interventional Study of people with Persistent Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Buenos Aires
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
France, Canada, United Kingdom, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
TerminatedNCT01894984

Risperidone Long-Acting Injection for schizophrenia

This study was terminated. It is testing Risperidone Long-Acting Injection for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Condition
Schizophrenia
Other study type icon
CompletedNCT01355952

An study of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia

This study is completed in the United States. It is testing Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss for schizophrenia.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.